<?xml version="1.0" encoding="UTF-8" ?><dbgapss xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dbgapssws.1.0.xsd"><Study uid="41298" whole_study_id="26160" phs="001417" v="2" p="1" createDate="2021-03-23T16:31:51-05:00" completedByGPADate="2021-03-25T13:28:52-05:00" modDate="2021-10-12T15:51:55-05:00" maxParentChildStudyModDate="2021-10-12T15:51:55-05:00" handle="MetastaticTumors_CellFree" num_participants="581"><StudyInfo accession="phs001417.v2.p1" parentAccession="phs001417.v2.p1"><BioProject id="PRJNA396638" entrez_id="396638" type="bp_admin_access"/><BioProject id="PRJNA396639" entrez_id="396639" type="bp_data_submission"/><StudyNameEntrez>Scalable Whole-exome Sequencing of Cell-free DNA Reveals High Concordance with Metastatic Tumors</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="Yes"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="Yes"><StudyType22 name="ncbi_for_sequence"/><StudyType22 name="whole_targ_genome"/><StudyType22 name="whole_targ_exome"/></StudyType21><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="Yes"><StudyType22 name="cnv_calls_from_sequencing"/><StudyType22 name="genotype_calls_from_sequence"/><StudyType22 name="somatic_snv"/></StudyType21><StudyType21 name="subject_samples" chosen="Yes"><StudyType22 name="germline"/><StudyType22 name="tumor_normal"/><StudyType22 name="dna"/></StudyType21><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>phenotype_data</StudyType><StudyType>individual_sequencing</StudyType><StudyType>germline</StudyType><StudyType>tumor_normal</StudyType><StudyType>dna</StudyType><StudyType>cnv_calls_from_sequencing</StudyType><StudyType>genotype_calls_from_sequence</StudyType><StudyType>somatic_snv</StudyType><StudyType>whole_genome</StudyType><StudyType>whole_exome</StudyType><StudyType>sra</StudyType></StudyTypes><SraStorages/></StudyInfo><Authority><ICs><IC id="4" name="NCI" is_funding_ic="false" is_admin_ic="false" primary="true"/></ICs><Persons><Person aid="8" auth="virtual" fname="Viktor" lname="Adalsteinsson" email="viktor@broadinstitute.org"><Role>PI</Role><Organization/></Person><Person aid="8" auth="virtual" fname="Adam" lname="Tracy" email="atracy@broadinstitute.org"><Role>PI_ASSIST</Role><Organization/></Person><Person nedid="0010579723" aid="1" auth="cit" login="wewu" fname="Wenyu" mname="" lname="Wu" email="wwu@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0011559580" aid="1" auth="cit" login="stefanov" fname="Stefan" mname="Alexandrov" lname="Stefanov" email="stefanov@mail.nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0014392987" aid="1" auth="cit" login="fingerma" fname="Ian" mname="Michael" lname="Fingerman" email="fingerma@mail.nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="none"><acknowledgement_statement>The authors would like to first and foremost acknowledge the courageous patients and their families for participation and contribution to this study. The authors would like to thank the generous support of the Gerstner Family Foundation. Initial technical studies for this work were also supported in part by Janssen Pharmaceuticals, Inc, and by the Koch Institute Support (core) grant P30-CA14051 from the National Cancer Institute. In addition, we would like to note that the matched tumor and germline samples were obtained as part of broader efforts to map the genomics of advanced cancers such as metastatic breast cancer (see phs001285.v1.p1) and metastatic prostate cancer (see phs000915.v1.p1).  Please see Adalsteinsson et al 2017 for a more complete description of the dataset.</acknowledgement_statement><ic_specific_access_term/><DUC universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC><DUC_PDF universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC_PDF><GSR_Access gsr_mode="unrest_access_by_timeout" gsr_mode_label="Unrestricted access (institution did not respond within six months)"/><ConsentGroup uid="2675" CGType="cg_class_DS" title="Disease-Specific (Cancer, MDS)" name="DS-CA-MDS" dac_uid="59" dac_name="NCI DAC" irb-approval-required="No"><Use-Restriction>Use of the data must be related to Cancer.
Use of the data includes methods development research (e.g., development of software or algorithms).

</Use-Restriction></ConsentGroup><ConsentGroup uid="2676" CGType="cg_class_DS" title="Disease-Specific (Breast Cancer, MDS)" name="DS-BRCA-MDS" dac_uid="59" dac_name="NCI DAC" irb-approval-required="No"><Use-Restriction>Use of the data must be related to Breast Cancer.
Use of the data includes methods development research (e.g., development of software or algorithms).

</Use-Restriction></ConsentGroup><ConsentGroup uid="2677" CGType="cg_class_DS" title="Disease-Specific (Prostate Cancer, MDS)" name="DS-PC-MDS" dac_uid="59" dac_name="NCI DAC" irb-approval-required="No"><Use-Restriction>Use of the data must be related to Prostate Cancer.
Use of the data includes methods development research (e.g., development of software or algorithms).

</Use-Restriction></ConsentGroup></Policy><SRA/><Documents/><Status uid="14" name="completed_by_gpa" title="Completed by GPA"/></Study><Study uid="26160" whole_study_id="26160" phs="001417" v="1" p="1" createDate="2017-07-21T16:01:40-05:00" completedByGPADate="2017-07-24T15:10:41-05:00" modDate="2021-03-23T16:32:00-05:00" maxParentChildStudyModDate="2021-03-23T16:32:00-05:00" handle="MetastaticTumors_CellFree" num_participants="581"><StudyInfo accession="phs001417.v1.p1" parentAccession="phs001417.v1.p1"><BioProject id="PRJNA396638" entrez_id="396638" type="bp_admin_access"/><BioProject id="PRJNA396639" entrez_id="396639" type="bp_data_submission"/><StudyNameEntrez>Scalable Whole-exome Sequencing of Cell-free DNA Reveals High Concordance with Metastatic Tumors</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="Yes"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="Yes"><StudyType22 name="ncbi_for_sequence"/><StudyType22 name="whole_targ_genome"/><StudyType22 name="whole_targ_exome"/></StudyType21><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="Yes"><StudyType22 name="cnv_calls_from_sequencing"/><StudyType22 name="genotype_calls_from_sequence"/><StudyType22 name="somatic_snv"/></StudyType21><StudyType21 name="subject_samples" chosen="Yes"><StudyType22 name="germline"/><StudyType22 name="tumor_normal"/><StudyType22 name="dna"/></StudyType21><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>phenotype_data</StudyType><StudyType>individual_sequencing</StudyType><StudyType>germline</StudyType><StudyType>tumor_normal</StudyType><StudyType>dna</StudyType><StudyType>cnv_calls_from_sequencing</StudyType><StudyType>genotype_calls_from_sequence</StudyType><StudyType>somatic_snv</StudyType><StudyType>whole_genome</StudyType><StudyType>whole_exome</StudyType><StudyType>sra</StudyType></StudyTypes><SraStorages/></StudyInfo><Authority><ICs><IC id="4" name="NCI" is_funding_ic="false" is_admin_ic="true" primary="true"/></ICs><Persons><Person aid="8" auth="virtual" fname="Viktor" lname="Adalsteinsson" email="viktor@broadinstitute.org"><Role>PI</Role><Organization/></Person><Person aid="8" auth="virtual" fname="Adam" lname="Tracy" email="atracy@broadinstitute.org"><Role>PI_ASSIST</Role><Organization/></Person><Person nedid="0010579723" aid="1" auth="cit" login="wewu" fname="Wenyu" mname="" lname="Wu" email="wwu@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0011559580" aid="1" auth="cit" login="stefanov" fname="Stefan" mname="Alexandrov" lname="Stefanov" email="stefanov@mail.nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0014392987" aid="1" auth="cit" login="fingerma" fname="Ian" mname="Michael" lname="Fingerman" email="fingerma@mail.nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="none"><acknowledgement_statement>The authors would like to first and foremost acknowledge the courageous patients and their families for participation and contribution to this study. The authors would like to thank the generous support of the Gerstner Family Foundation. Initial technical studies for this work were also supported in part by Janssen Pharmaceuticals, Inc, and by the Koch Institute Support (core) grant P30-CA14051 from the National Cancer Institute. In addition, we would like to note that the matched tumor and germline samples were obtained as part of broader efforts to map the genomics of advanced cancers such as metastatic breast cancer (see phs001285.v1.p1) and metastatic prostate cancer (see phs000915.v1.p1).  Please see Adalsteinsson et al 2017 for a more complete description of the dataset.</acknowledgement_statement><ic_specific_access_term/><DUC universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC><DUC_PDF universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC_PDF><GSR_Access gsr_mode="unrest_access_by_timeout" gsr_mode_label="Unrestricted access (institution did not respond within six months)"/><ConsentGroup uid="2675" CGType="cg_class_DS" title="Disease-Specific (Cancer, MDS)" name="DS-CA-MDS" dac_uid="59" dac_name="NCI DAC" irb-approval-required="No"><Use-Restriction>Use of the data must be related to Cancer.
Use of the data includes methods development research (e.g., development of software or algorithms).

</Use-Restriction></ConsentGroup><ConsentGroup uid="2676" CGType="cg_class_DS" title="Disease-Specific (Breast Cancer, MDS)" name="DS-BRCA-MDS" dac_uid="59" dac_name="NCI DAC" irb-approval-required="No"><Use-Restriction>Use of the data must be related to Breast Cancer.
Use of the data includes methods development research (e.g., development of software or algorithms).

</Use-Restriction></ConsentGroup><ConsentGroup uid="2677" CGType="cg_class_DS" title="Disease-Specific (Prostate Cancer, MDS)" name="DS-PC-MDS" dac_uid="59" dac_name="NCI DAC" irb-approval-required="No"><Use-Restriction>Use of the data must be related to Prostate Cancer.
Use of the data includes methods development research (e.g., development of software or algorithms).

</Use-Restriction></ConsentGroup></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study></dbgapss>